Overview
Cough assisted devices, also known as mechanical insufflators and exsufflators, are specialised non-invasive medical devices that emulate the body's natural coughing mechanism. They work by simultaneously providing positive pressure to the airways to inflate the lungs (insufflation), followed by a rapid switch to negative pressure (exsufflation), resulting in a strong expiratory flow that mobilizes and eliminates mucus and secretions from the airways. It is primarily used for individuals with disorders that affect the muscles involved in coughing, such as neuromuscular disorders, spinal cord injuries, or specific respiratory conditions. Their non-invasive design eliminates the need fora surgical procedure, making them suitable for both hospital and home-care settings. Recent innovative devices have adjustable pressure settings, multiple interface options (such as mouthpieces or tracheostomy adapters), and digital controls, which have improved both patient comfort and clinical outcomp>

To learn more about this report, download the PDF brochure
Rising incidence of respiratory and neuromuscular disorders fuels the cough assisted devices market
The rising global prevalence of chronic respiratory diseases, including COPD, asthma, and cystic fibrosis, as well as increasing neuromuscular disorders like muscular dystrophy, spinal muscular atrophy, and ALS, is a primary driver of the cough assisted devices market. For instance, according to an article published by WHO, chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death, causing 3.5million deaths in 2021, approximately 5% of all global deaths. These disorders often weaken the diaphragm and intercostal muscles, limiting the body's capacity to cough, thereby increasing the risk of airway obstruction and respiratory infections. Cough assisted devices address this clinical need by offering a safe and non-invasive approach, by delivering positive pressure to inflate the lungs, fod by a rapid shift to negative pressure to simulate a strong exhalation to safely mobilize secretions.
With the increasing prevalence of chronic diseases, particularly among the elderly, the number of patients requiring long-term respiratory support increases. Further, the growing patients' preference for less invasive and more independent treatment options, has accelerated the demand for cough assisted devices in both hospital and home healthcare settings.
Shift towards portable and automatic cough assisted devices
The increasing demand for portable devices is reshaping healthcare practice by taking respiratory care beyond hospitals and clinics. Portable cough assisted devices are small, lightweight, and battery-powered, making them ideal for use in home-care settings and outpatient clinics. These devices assist patients with weak cough reflexes by delivering synchronized positive and negative pressure cycles and facilitate secretion clearance. Portable devices are particularly advantageous for the elderly and chronically ill patients as they enable them to use these devices independently, and also reduce their number of hospital visits.
Automatic portable cough assisted devices represent a major milestone in respiratory care. These devices offer smart, pre-programmed pressure cycles that simulate natural coughing without the need for human intervention. These devices have user-friendly interfaces and advanced capabilities like as Internet of Medical Things (IoMT) connectivity, which allows seamless remote data sharing between patients and caregivers. In addition to improving care quality, this connectivity streamlines workflow efficiency and enhances clinical efficiency and patient comfort.
Recent developments in the cough assisted devices market
Recent innovations and regulatory milestones are reshaping the cough assisted devices market, enhancing clinical efficacy, patient comfort, and remote monitoring capabilities. Some of these include:
- In July 2024, Swiss Medtech company Siva Health AG received CE Mark approval for the first automated AI-based continuous ambulatory cough monitoring system, which is a medical-grade wearable solution for objective long-term cough tracking in clinical and trial settings
- In October 2022, ABM Respiratory Care-s BiWaze, an automatic cough-assisted system, received CE Mark approval, enabling distribution of the airway clearance device in hospitals, homes, and long-term care settings across Europe
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global cough assisted devices market is marked by the presence of established and emerging market players such as Koninklijke Philips N.V.; Oxycare Medical Group; Ventec Life Systems; Wave Healthcare; Baxter International Inc.; Air Liquide Medical Systems; West Care Medical; Inogen, Inc.; Dima Italia Srl; and Breas Medical AB, among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| ~7% | |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product type, Choice of Delivery, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Koninklijke Philips N.V.; Oxycare Medical Group; Ventec Life Systems; Wave Healthcare; Baxter International Inc.; Air Liquide Medical Systems; West Care Medical; Inogen, Inc.; Dima Italia Srl; and Breas Medical AB among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Cough Assisted Devices Market Segmentation
This report by Medi-Tech Insights provides thesize of the global cough assisted devices market at theregional and country-level from 2023 to 2030. The report further segments the market based on product type, procedure, and end-user.
Market Size & Forecast (2023-2030), By Product type, USD Million
- Automatic Cough Assisted Devices
- Manual Cough Assisted Devices
Market Size & Forecast (2023-2030), By Choice of Delivery, USD Million
"list-style-type: none">- Mouthpiece
- Face Mask
- Adapter
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
-
- Hospitals
- Home-care Settings
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the cough assisted devices market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the cough assisted devices market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.